Idecabtagen-Viceucel
| Idecabtagen-Viceucel | |
|---|---|
| Term | Idecabtagen-Viceucel |
| Short definition | Idecabtagen-Viceucel (I-deh-KAB-tuh-jeen vik-LOO-sel) A drug used to treat adults with multiple myeloma who have been treated with at least four other cancer therapies, including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulating agent, relapsed (come back) or did not improve. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Idecabtagen-Viceucel - (pronounced) (I-deh-KAB-tuh-jeen vik-LOO-sel) A drug used to treat adults with multiple myeloma who have been treated with at least four other cancer therapies, including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulating agent, relapsed (come back) or did not improve. It is also being studied in the treatment of other types of cancer. Idecabtagene-Viceucel is made using a patient's T cells (a type of cell in the immune system). A gene for a special receptor called the chimeric antigen receptor (CAR) is added to the T cells in the laboratory. Large numbers of these modified T cells, known as CAR T cells, are cultivated in the laboratory and given to the patient by infusion. Idecabtagene-Vicleucel attaches to a protein called BCMA, which is found on myeloma cells and some types of immune cells. This helps the body's immune system kill cancer cells. Idecabtagene Vicleucel is a type of CAR T cell therapy. Also called Abecma
External links
- Medical encyclopedia article on Idecabtagen-Viceucel
- Wikipedia's article - Idecabtagen-Viceucel
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski